Gridai Technologies Corp

Penny Stocks Biotech Stocks Healthcare Stocks

$4.17

+0.38 (+10.03%)

As of Aug 14, 10:23 PM ET ·

Analyst Consensus

Strong Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 3 50%

Sell 3 50%

Price Target

Analyst Price Target +936.0% upside

Low Target $28.55

Average Target $43.20

High Target $44.32

Current Price $4.17

Current
$4.17

Target
$43.20

$28.55 $43.20 avg $44.32

Scenario Analysis

Bear Case

$28.55

584.7%

Low target

Base Case

$43.20

+936.0%

Avg target

Bull Case

$44.32

+962.8%

High target

Risk/Reward

1.6x

Balanced

Price in Context

52-Week High

$6.93

-39.8% from high

52-Week Low

$1.08

+286.1% from low

Target vs 52W High

$43.20

+523.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+3.3%
AMGN Amgen Inc	Hold	43	49%	$190.87	-54.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-13.3%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.4%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-53.9%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.0%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.4%